- Home
- SNRE vs ALKS Comparison
SNRE vs ALKS Comparison
Compare SNRE & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNRE
- ALKS
- Stock Information
- Founded
- SNRE 2000
- ALKS 1987
- Country
- SNRE Switzerland
- ALKS Ireland
- Employees
- SNRE N/A
- ALKS N/A
- Industry
- SNRE Cable & Other Pay Television Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SNRE Telecommunications
- ALKS Health Care
- Exchange
- SNRE Nasdaq
- ALKS Nasdaq
- Market Cap
- SNRE 3.8B
- ALKS 4.5B
- IPO Year
- SNRE N/A
- ALKS 1991
- Fundamental
- Price
- SNRE $54.78
- ALKS $30.13
- Analyst Decision
- SNRE
- ALKS Buy
- Analyst Count
- SNRE 0
- ALKS 12
- Target Price
- SNRE N/A
- ALKS $38.33
- AVG Volume (30 Days)
- SNRE 215.9K
- ALKS 1.9M
- Earning Date
- SNRE 06-18-2025
- ALKS 05-01-2025
- Dividend Yield
- SNRE 6.79%
- ALKS N/A
- EPS Growth
- SNRE N/A
- ALKS N/A
- EPS
- SNRE N/A
- ALKS 2.09
- Revenue
- SNRE $3,330,464,145.00
- ALKS $1,513,770,000.00
- Revenue This Year
- SNRE N/A
- ALKS N/A
- Revenue Next Year
- SNRE N/A
- ALKS $4.09
- P/E Ratio
- SNRE N/A
- ALKS $14.50
- Revenue Growth
- SNRE N/A
- ALKS N/A
- 52 Week Low
- SNRE $42.35
- ALKS $22.90
- 52 Week High
- SNRE $54.69
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- SNRE N/A
- ALKS 51.87
- Support Level
- SNRE N/A
- ALKS $29.78
- Resistance Level
- SNRE N/A
- ALKS $31.99
- Average True Range (ATR)
- SNRE 0.00
- ALKS 1.04
- MACD
- SNRE 0.00
- ALKS 0.42
- Stochastic Oscillator
- SNRE 0.00
- ALKS 64.09
About SNRE Sunrise Communications AG American Depositary Shares representing Class A shares
Sunrise Communications AG is a telecommunications company. The company provides high-quality mobile, landline, broadband, and TV services to residential customers. The company also offers business customers 360-degree communications solutions and integrated ICT solutions for connectivity, security, and IoT from a single source to take companies forward in their quest for digitalization. It has three reportable segments being Residential customers; Business customers and Wholesale and Infrastructure and Support functions.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.